Page last updated: 2024-08-24

telmisartan and Obesity

telmisartan has been researched along with Obesity in 57 studies

Research

Studies (57)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (22.81)	29.6817
2010's	37 (64.91)	24.3611
2020's	7 (12.28)	2.80

Authors

Authors	Studies
Frydrychowicz, A; Hübner, N; Kuerschner, L; Nickel, L; Othman, A; Raasch, W; Rawish, E; Saar, K; Schuster, F; Stölting, I	1
He, J; Huang, C; Huang, H; Huang, Y; Li, R; Li, Y; Liu, Q; Tang, Q; Wu, T; Zhang, G; Zhang, J; Zhang, Z; Zhao, Y; Zhou, J	1
Bazylevych, AY; Bochar, OM; Bochar, VT; Faynyk, AF; Kuzminov, YB; Sklyarova, HY	1
Chen, W; Dang, C; Diao, D; Li, M; Wang, Y; Xie, X; Zhang, X	1
Hövener, JB; Huber, G; Huber, L; Jurk, D; Matschl, U; Ogrodnik, M; Peschke, E; Raasch, W; Schwaninger, M; Stölting, I; Wenzel, J; Will, O	1
Ameen, O; Motawea, SM; Naguib, YM; Rizk, MS; Samaka, RM	1
Beckmann, L; Busch, H; Freitag, M; Freschi, ML; Fuchs, B; Galuska, CE; Hirose, M; Huber, G; Ibrahim, SM; Knobloch, JK; Künstner, A; Langan, EA; Matschl, U; Raasch, W; Stölting, I	1
Banks, WA; Huber, G; Hübner, N; Raasch, W; Saar, K; Schuster, F; Stölting, I; Wing, EE	1
Cheon, HG; Choi, HE; Jeon, EJ; Kim, DY; Lee, NH	1
Alenina, N; Bader, M; Castro E Souza, LA; Dapper, C; Raasch, W; Schuster, F; Stölting, I; Vogt, F	1
Bentzen, BH; Grunnet, M; Hansen, HH; Hyveled-Nielsen, L; Lassen, JB; Sundgreen, C	1
Barykina, IN; Chumachok, EV; Ledyaeva, AA; Mazina, G; Nedogoda, SV; Salasyuk, AS; Tsoma, VV	1
Sharma, K; Sweiss, N	1
Kinoshita, S; Nakamoto, H; Nishida, E; Ryuzaki, M; Sone, M	1
Barkhausen, J; Hübel, N; Mildner, M; Müller-Fielitz, H; Raasch, W; Vogt, FM	1
Liu, Z; Lu, F; Peng, J; Tang, M; Wang, Z; Zhang, H; Zhang, W; Zhao, Y; Zhong, M	1
Graus-Nunes, F; Mandarim-de-Lacerda, CA; Penna-de-Carvalho, A; Rabelo-Andrade, J; Souza-Mello, V	1
Bochar, OM	1
Bader, M; Barkhausen, J; Raasch, W; Santos, RA; Schuchard, J; Schuster, F; Stölting, I; Thorns, C; Vogt, FM; Winkler, M	1
Bader, M; Barkhausen, J; Raasch, W; Schuchard, J; Stölting, I; Thorns, C; Vogt, FM; Winkler, M	1
Choi, GJ; Kang, H; Kim, HM; Kim, J	1
Alhusseini, NF; Ali, SI; Atteia, HH; Hasan, RA; Idris, RA	1
Barini, A; Cardillo, C; Di Daniele, N; Mores, N; Schinzari, F; Tesauro, M; Veneziani, A	1
Dahlöf, B; Ritz, E	2
Sharma, AM	2
Anderwald-Stadler, M; Bergmann, A; Clodi, M; Hülsmann, M; Luger, A; Morgenthaler, NG; Mörtl, D; Pacher, R; Pacini, G; Resl, M; Riedl, M; Stelzeneder, D; Struck, J; Tura, A	1
Hirose, H; Itoh, H; Kawabe, H; Komiya, N; Saito, I	1
Cao, T; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Ma, S; Tepel, M; Yan, Z; Yang, D; Zhu, Z	1
Aguila, MB; Cardoso-de-Lemos, FS; de Carvalho, L; Gregório, BM; Mandarim-de-Lacerda, CA; Souza-Mello, V	1
Awata, T; Ikebukuro, K; Inukai, K; Ito, D; Katayama, S; Kurihara, S; Ono, H; Sumita, T; Watanabe, M	1
Davidai, G; Henry, R; Hsueh, W; Mudaliar, S	1
Fernández-Fernández, FJ	1
Clemenz, M; Foryst-Ludwig, A; Hartge, M; Hess, K; Kintscher, U; Marx, N; Sprang, C; Unger, T	1
Aminuddin, A; Bukhari, A; Fujisaka, S; Ikutani, M; Kanatani, Y; Kobayashi, M; Nagai, Y; Senda, S; Suzuki, H; Tabuchi, Y; Takasaki, I; Takatsu, K; Tobe, K; Tsuneyama, K; Usui, I; Yamazaki, Y	1
Alfieri, A; Buono, P; Franzese, A; Labruna, G; Licenziati, MR; Mancini, A; Musa, CV; Pasanisi, F; Sacchetti, L; Valerio, G	1
Aguila, MB; da Silva Faria, T; Gregório, BM; Mandarim-de-Lacerda, CA; Relvas-Lucas, B; Souza-Mello, V	1
Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Sakai, H; Shimizu, M; Tanaka, T; Tsurumi, H; Yasuda, Y	1
Dong, YF; Fukuda, M; Kataoka, K; Kim-Mitsuyama, S; Nakamura, T; Ogawa, H; Tokutomi, Y; Toyama, K; Yasuda, O	1
Matsuura, K; Mori, Y; Tanaka, T; Utsunomiya, K; Yokoyama, J	1
Sahebkar, A	1
Hu, TJ; Huang, GZ; Tang, YH; Wang, BY; Zhang, B; Zhang, L; Zhang, XY; Zhong, Y	1
Jöhren, O; Miesel, A; Müller-Fielitz, H; Raasch, W; Vogt, FM	1
Heidbreder, M; Jöhren, O; Landolt, J; Müller-Fielitz, H; Raasch, W; Vogt, FM; Werth, S	1
Adamczak, M; Chudek, J; Kubik, M; Wiecek, A	1
Hirooka, Y; Kishi, T; Konno, S; Sunagawa, K	1
Fukuda, D; Hirata, Y; Kurobe, H; Maeda, N; Masuzaki, H; Sakaue, H; Sata, M; Sato, H; Shimabukuro, M; Shimomura, I; Shiota, A; Soeki, T; Uematsu, E	1
Ley, L; Schumacher, H	1
Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T; Yamamoto, H	1
Engeli, S; Gorzelniak, K; Janke, J; Luft, FC; Sharma, AM	1
Clasen, R; Clemenz, M; Foryst-Ludwig, A; Kintscher, U; Krikov, M; Schupp, M; Sprang, C; Thöne-Reineke, C; Unger, T	1
Araki, K; Kakuma, T; Katsuragi, I; Masaki, T; Tanaka, K; Yoshimatsu, H	1
Burnier, M; Dulloo, AG; Montani, JP; Perregaux, C; Zanchi, A	1
Itoh, Y; Mori, Y; Tajima, N	1
Davidson, J; Koval, S; Lacourcière, Y; Sharma, AM	1
Janez, A; Jensterle, M; Kocjan, T; Meden-Vrtovec, H; Pfeifer, M; Prezelj, J; Vrtovec, B	1

Reviews

6 review(s) available for telmisartan and Obesity

Article	Year
Adiponectin effects on the kidney. Best practice & research. Clinical endocrinology & metabolism, 2014, Volume: 28, Issue:1 Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan	2014
Effects of telmisartan on fat distribution: a meta-analysis of randomized controlled trials. Current medical research and opinion, 2016, Volume: 32, Issue:7 Topics: Adipose Tissue; Benzimidazoles; Benzoates; Body Fat Distribution; Body Weight; Humans; Obesity; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan	2016
The value of current interventions for obesity. Nature clinical practice. Cardiovascular medicine, 2008, Volume: 5 Suppl 1 Topics: Adipogenesis; Angiotensin II Type 1 Receptor Blockers; Bariatric Surgery; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Obesity; Risk Factors; Telmisartan; Weight Loss	2008
Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients). Current medical research and opinion, 2013, Volume: 29, Issue:1 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Humans; Hypertension; MEDLINE; Obesity; Risk Factors; Telmisartan	2013
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials. Hypertension research : official journal of the Japanese Society of Hypertension, 2013, Volume: 36, Issue:4 Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Hypertension, Renal; Imidazoles; Interleukin-6; Obesity; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Stents; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan	2013
The obese patient with diabetes mellitus: from research targets to treatment options. The American journal of medicine, 2006, Volume: 119, Issue:5 Suppl 1 Topics: Adipogenesis; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Obesity; Renin-Angiotensin System; Telmisartan; Weight Loss	2006

Trials

11 trial(s) available for telmisartan and Obesity

Article	Year
Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension. Clinical drug investigation, 2013, Volume: 33, Issue:8 Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Obesity; Overweight; Perindopril; Single-Blind Method; Telmisartan	2013
Effectiveness of using long-acting angiotensin II type 1 receptor blocker in Japanese obese patients with metabolic syndrome on morning hypertension monitoring by using telemedicine system (FUJIYAMA study). Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:7 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cholesterol, LDL; Female; Humans; Hypertension; Japan; Male; Metabolic Syndrome; Middle Aged; Obesity; Prospective Studies; Telemedicine; Telmisartan; Tetrazoles	2014
Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure. Hypertension research : official journal of the Japanese Society of Hypertension, 2015, Volume: 38, Issue:2 Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; China; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Male; Metabolic Diseases; Middle Aged; Obesity; Telmisartan; Treatment Outcome	2015
Combined effect of appointment telmisartan and atorvastatin on hemodynamic indicators and the indicators of lipid profile in patients with arterial hypertension combined with obesity and steatohepatitis. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2014, Volume: 67, Issue:2 Pt 2 Topics: Acetamides; Adipokines; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Benzimidazoles; Benzoates; Breath Tests; Cholesterol, LDL; Drug Therapy, Combination; Fatty Liver; Female; Hemodynamics; Heptanoic Acids; Humans; Hypertension; Lipids; Male; Middle Aged; Obesity; Pyrroles; Telmisartan; Triglycerides	2014
Interactions of glucose metabolism and chronic heart failure. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2009, Volume: 117, Issue:3 Topics: Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; Chronic Disease; Heart Failure; Humans; Lipid Metabolism; Middle Aged; Obesity; Telmisartan; Tetrazoles	2009
Effects of telmisartan therapy on metabolic profiles and serum high molecular weight (HMW)-adiponectin level in Japanese male hypertensive subjects with abdominal obesity. Journal of atherosclerosis and thrombosis, 2009, Volume: 16, Issue:2 Topics: Adiponectin; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Lipoproteins, LDL; Male; Metabolome; Obesity; Sex Factors; Telmisartan	2009
Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:17 Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Hypertension; Insulin Resistance; Japan; Lipoproteins, LDL; Male; Metabolic Syndrome; Middle Aged; Obesity; Oxidative Stress; PPAR gamma; Telmisartan; Tetrazoles	2010
Telmisartan effects on insulin resistance in obese or overweight adults without diabetes or hypertension. Journal of clinical hypertension (Greenwich, Conn.), 2010, Volume: 12, Issue:9 Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Obesity; Overweight; Telmisartan	2010
Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE). Advances in therapy, 2011, Volume: 28, Issue:8 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Blood Pressure; Female; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypertension; Insulin Resistance; Male; Obesity; Telmisartan; Tetrazoles; Valine; Valsartan	2011
Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity. Saudi medical journal, 2011, Volume: 32, Issue:10 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; China; Female; Humans; Hypertension; Insulin Resistance; Intra-Abdominal Fat; Male; Middle Aged; Obesity; Telmisartan	2011
Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study. Cardiovascular diabetology, 2007, Oct-02, Volume: 6 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diastole; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Obesity; Placebos; Single-Blind Method; Systole; Telmisartan; Tetrazoles; Valine; Valsartan	2007

Other Studies

40 other study(ies) available for telmisartan and Obesity

Article	Year
Telmisartan prevents development of obesity and normalizes hypothalamic lipid droplets. The Journal of endocrinology, 2020, 01-01, Volume: 244, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Animal Feed; Animals; Diet, High-Fat; Hypothalamus; Leptin; Lipid Droplets; Lipid Metabolism; Mice; Mice, Inbred C57BL; Obesity; Telmisartan; Weight Gain	2020
Telmisartan attenuates obesity-induced insulin resistance via suppression of AMPK mediated ER stress. Biochemical and biophysical research communications, 2020, 03-12, Volume: 523, Issue:3 Topics: 3T3-L1 Cells; AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Endoplasmic Reticulum Stress; Enzyme Activation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Telmisartan	2020
The effect of therapy with olmesartan or telmisartan in patients with arterial hypertension combined with obesity. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2020, Volume: 73, Issue:2 Topics: Blood Pressure; Humans; Hypertension; Imidazoles; Obesity; Telmisartan; Tetrazoles	2020
Obesity and metabolic syndrome related macrophage promotes PD-L1 expression in TNBC through IL6/JAK/STAT pathway and can be reversed by telmisartan. Cancer biology & therapy, 2020, 12-01, Volume: 21, Issue:12 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; B7-H1 Antigen; Biomarkers, Tumor; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Metabolic Syndrome; Obesity; Rats; Rats, Wistar; Telmisartan; Triple Negative Breast Neoplasms	2020
Telmisartan prevents high-fat diet-induced neurovascular impairments and reduces anxiety-like behavior. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2021, Volume: 41, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anxiety; Diet, High-Fat; Disease Models, Animal; Male; Mice; Obesity; Telmisartan	2021
Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension. Cardiovascular diabetology, 2021, 03-24, Volume: 20, Issue:1 Topics: Adiposity; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Disease Models, Animal; Hypertension; Intra-Abdominal Fat; Kidney; Male; Obesity; Rats, Wistar; Telmisartan	2021
Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect. Pharmacological research, 2021, Volume: 170 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Bacteria; Diet; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Feces; Gastrointestinal Microbiome; Mice; Obesity; Rats; Rats, Sprague-Dawley; Telmisartan; Weight Gain	2021
Telmisartan prevents diet-induced obesity and preserves leptin transport across the blood-brain barrier in high-fat diet-fed mice. Pflugers Archiv : European journal of physiology, 2018, Volume: 470, Issue:11 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Blood-Brain Barrier; Body Weight; Cell Line; Diet, High-Fat; Energy Metabolism; Humans; Leptin; Male; Mice; Mice, Inbred C57BL; Obesity; Telmisartan	2018
Telmisartan induces browning of fully differentiated white adipocytes via M2 macrophage polarization. Scientific reports, 2019, 02-04, Volume: 9, Issue:1 Topics: Adipocytes, Brown; Adipocytes, White; Adipose Tissue, White; Angiotensin II Type 1 Receptor Blockers; Animals; Catecholamines; Cell Differentiation; Clodronic Acid; Culture Media, Conditioned; Humans; Insulin Resistance; Macrophage Activation; Macrophages; Male; Mice; Obesity; PPAR gamma; RAW 264.7 Cells; Receptors, Cytoplasmic and Nuclear; Telmisartan	2019
The antiobese effect of AT1 receptor blockade is augmented in mice lacking Mas. Naunyn-Schmiedeberg's archives of pharmacology, 2019, Volume: 392, Issue:7 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Body Weight; Diet, High-Fat; Mice, Knockout; Obesity; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Telmisartan	2019
Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats. Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Antihypertensive Agents; Appetite; Appetite Depressants; Benzimidazoles; Benzoates; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cardiovascular Diseases; Dose-Response Relationship, Drug; Energy Intake; Feeding Behavior; Heart Rate; Male; Metoprolol; Obesity; Rats, Sprague-Dawley; Sympathomimetics; Telmisartan	2013
Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats. British journal of pharmacology, 2014, Volume: 171, Issue:3 Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Antihypertensive Agents; Behavior, Animal; Benzimidazoles; Benzoates; Diet, High-Fat; Dietary Sucrose; Drug Therapy, Combination; Energy Intake; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain	2014
Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan. Experimental physiology, 2014, Dec-01, Volume: 99, Issue:12 Topics: Adipose Tissue; Animals; Benzimidazoles; Benzoates; Diet, High-Fat; Gene Expression; Insulin Resistance; Male; Mice; Mice, Obese; Obesity; Peroxisome Proliferator-Activated Receptors; Telmisartan	2014
Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway. British journal of pharmacology, 2015, Volume: 172, Issue:15 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Benzimidazoles; Benzoates; Diet; Energy Intake; Energy Metabolism; Insulin Resistance; Leptin; Male; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Telmisartan; Weight Gain; Weight Loss	2015
The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats. British journal of pharmacology, 2016, Volume: 173, Issue:10 Topics: Animals; Benzimidazoles; Benzoates; Body Weight; Brain; Diet; Male; Obesity; Rats; Rats, Transgenic; Renin-Angiotensin System; Telmisartan	2016
Renoprotective effect of a combination of garlic and telmisartan against ischemia/reperfusion-induced kidney injury in obese rats. Free radical research, 2016, Volume: 50, Issue:9 Topics: Acute Kidney Injury; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Garlic; Kidney; Obesity; Rats; Reperfusion Injury; Telmisartan	2016
Beneficial Effects of Apelin on Vascular Function in Patients With Central Obesity. Hypertension (Dallas, Tex. : 1979), 2017, Volume: 69, Issue:5 Topics: Acetylcholine; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Annexins; Apelin; Benzimidazoles; Benzoates; Endothelium, Vascular; Female; Forearm; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Nitric Oxide; Nitroprusside; Obesity; omega-N-Methylarginine; Pyridines; Regional Blood Flow; Telmisartan; Vasodilation	2017
A new dawn in cardiovascular protection: total cardiovascular risk: rigorous treatment of risk factors. Introduction. Nature clinical practice. Cardiovascular medicine, 2008, Volume: 5 Suppl 1 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Body Size; Cardiovascular Diseases; Humans; Life Style; Metabolic Syndrome; Obesity; Ramipril; Renin-Angiotensin System; Risk Assessment; Risk Factors; Telmisartan	2008
Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways. Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:4 Topics: Adipocytes; Adipose Tissue; Analysis of Variance; Animals; Benzimidazoles; Benzoates; Blotting, Western; Cell Differentiation; Cells, Cultured; Dietary Fats; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Fluorescent Antibody Technique; Mice; Mice, Knockout; Obesity; PPAR delta; Signal Transduction; Telmisartan; Uncoupling Agents; Weight Gain	2010
Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet. Clinical science (London, England : 1979), 2010, Jun-08, Volume: 119, Issue:6 Topics: Adipocytes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Drug Therapy, Combination; Energy Intake; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metabolic Syndrome; Metformin; Mice; Mice, Inbred C57BL; Obesity; Pancreas; Pyrazines; Sitagliptin Phosphate; Telmisartan; Triazoles	2010
Telmisartan and obesity. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:19 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Humans; Obesity; PPAR delta; Risperidone; Schizophrenia; Telmisartan; Weight Loss	2010
PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice. Cardiovascular diabetology, 2010, Oct-18, Volume: 9 Topics: Abdominal Fat; Animals; Anti-Inflammatory Agents; Antigens, Differentiation; Benzimidazoles; Benzoates; CD3 Complex; Chemokine CXCL12; Chemotaxis; Dietary Fats; Disease Models, Animal; Inflammation; Insulin Resistance; Lymphocyte Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Obesity; PPAR gamma; Rosiglitazone; T-Lymphocytes; Telmisartan; Thiazolidinediones; Time Factors	2010
Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice. Endocrinology, 2011, Volume: 152, Issue:5 Topics: Adipocytes; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Benzimidazoles; Benzoates; Body Weight; CD11c Antigen; Cell Adhesion Molecules; Cell Size; Dietary Fats; Epididymis; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation; Glucose; Insulin Resistance; Lectins, C-Type; Macrophages; Male; Mice; Mice, Inbred C57BL; Obesity; Oligonucleotide Array Sequence Analysis; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Tumor Necrosis Factor-alpha	2011
Four novel UCP3 gene variants associated with childhood obesity: effect on fatty acid oxidation and on prevention of triglyceride storage. International journal of obesity (2005), 2012, Volume: 36, Issue:2 Topics: Age of Onset; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Child; Child, Preschool; Fatty Acids; Female; Genetic Variation; HEK293 Cells; Humans; Infant; Ion Channels; Italy; Lipid Metabolism; Male; Mitochondrial Proteins; Muscle, Skeletal; Mutation; Obesity; Oxidation-Reduction; Phosphorylation; Telmisartan; Triglycerides; Uncoupling Protein 3	2012
Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice. Pancreas, 2011, Volume: 40, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Insulin; Islets of Langerhans; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Obesity; Pancreas; Pancreas, Exocrine; Pyrazines; Sitagliptin Phosphate; Telmisartan; Triazoles	2011
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice. Biochemical and biophysical research communications, 2011, Jun-24, Volume: 410, Issue:1 Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Azoxymethane; Benzimidazoles; Benzoates; Captopril; Colonic Neoplasms; Cyclooxygenase 2; Deoxyguanosine; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Precancerous Conditions; Renin-Angiotensin System; RNA, Messenger; Telmisartan; Tumor Necrosis Factor-alpha	2011
Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity. Biochemical and biophysical research communications, 2011, Jul-08, Volume: 410, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anilides; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Obesity; PPAR gamma; Telmisartan	2011
Metabolic improvement by telmisartan beyond angiotensin receptor blockade: role of adipokines. Arquivos brasileiros de endocrinologia e metabologia, 2011, Volume: 55, Issue:5 Topics: Adipokines; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Humans; Insulin Resistance; Obesity; Resistin; Telmisartan; Tumor Necrosis Factor-alpha	2011
Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats. British journal of pharmacology, 2012, Volume: 165, Issue:8 Topics: Adipose Tissue; Adrenocorticotropic Hormone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Corticosterone; Drug Therapy, Combination; Feeding Behavior; Heart Rate; Leptin; Male; Obesity; Ramipril; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain	2012
Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARγ target gene regulation. Endocrinology, 2012, Volume: 153, Issue:3 Topics: Adipocytes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Body Weight; Gene Expression Regulation; Glucose Tolerance Test; Hemodynamics; Hypothalamus; Insulin; Insulin Resistance; Male; Models, Biological; Obesity; PPAR gamma; Rats; Rats, Inbred SHR; Telmisartan; Tetrazoles	2012
Telmisartan improves cardiometabolic profile in obese patients with arterial hypertension. Kidney & blood pressure research, 2012, Volume: 35, Issue:4 Topics: Adult; Aged; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Insulin Resistance; Male; Metabolome; Middle Aged; Obesity; Telmisartan	2012
Sympathoinhibitory effects of telmisartan through the reduction of oxidative stress in the rostral ventrolateral medulla of obesity-induced hypertensive rats. Journal of hypertension, 2012, Volume: 30, Issue:10 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Brain Stem; Heart Rate; Hypertension; Male; Microinjections; Norepinephrine; Obesity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Telmisartan; Thiobarbituric Acid Reactive Substances	2012
Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice. Cardiovascular diabetology, 2012, Nov-08, Volume: 11 Topics: Adipocytes; Administration, Oral; AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cell Line; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Fatty Acid Transport Proteins; Glucose Transporter Type 4; Hypertrophy; Insulin; Islets of Langerhans; Male; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; NAD; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; PPAR gamma; RNA, Messenger; Signal Transduction; Sirtuin 1; Telmisartan; Time Factors; Trans-Activators; Transcription Factors	2012
Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:5 Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Differentiation; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Telmisartan	2002
Introduction. Acta diabetologica, 2005, Volume: 42 Suppl 1 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Hypoglycemic Agents; Obesity; Telmisartan	2005
PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:1 Topics: 3T3-L1 Cells; Adipocytes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Cycloheximide; Insulin Resistance; Irbesartan; Mice; Obesity; PPAR gamma; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Rats; Rats, Zucker; Receptor, Angiotensin, Type 2; Telmisartan; Tetrazoles	2005
Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:1 Topics: Adiponectin; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Body Weight; Carrier Proteins; Diet; Eating; Ion Channels; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mitochondrial Proteins; Obesity; Oxygen Consumption; RNA, Messenger; Telmisartan; Triglycerides; Uncoupling Protein 1	2006
Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties. American journal of physiology. Endocrinology and metabolism, 2007, Volume: 293, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Drug Evaluation, Preclinical; Drug Interactions; Insulin; Insulin Resistance; Male; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Telmisartan; Thiazolidinediones; Weight Gain	2007
Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity. American journal of hypertension, 2007, Volume: 20, Issue:4 Topics: Adipocytes; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Calcium Channel Blockers; Cell Size; Diabetes Mellitus, Type 2; Disease Models, Animal; Insulin; Intra-Abdominal Fat; Male; Obesity; PPAR gamma; Random Allocation; Rats; Rats, Long-Evans; Telmisartan; Tetrazoles; Valine; Valsartan	2007
Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series. Croatian medical journal, 2007, Volume: 48, Issue:6 Topics: Adult; Androgens; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Body Mass Index; Fasting; Female; Humans; Hypertension; Menstruation; Obesity; Polycystic Ovary Syndrome; Telmisartan; Treatment Outcome	2007